Results 121 to 130 of about 666,379 (164)

An overview of real‐world data sources for oncology and considerations for research

Ca-A Cancer Journal for Clinicians, 2022
Lynne Penberthy, Donna R Rivera, Jennifer L Lund, Msph   +2 more
exaly  

Health insurance status and cancer stage at diagnosis and survival in the United States

Ca-A Cancer Journal for Clinicians, 2022
Jingxuan Zhao, Xuesong Han, Leticia M Nogueira   +2 more
exaly  

An overview of precision oncology basket and umbrella trials for clinicians

Ca-A Cancer Journal for Clinicians, 2020
Kristian Thorlund, Edward J Mills
exaly  

Cancer statistics, 2017

Ca-A Cancer Journal for Clinicians, 2017
Rebecca L Siegel, Kimberly D Miller
exaly  

Effect of Acipimox on serum lipids and apoproteins in type II hyperlipoproteinemia

, 1987
Cristiano Capurso, Francesco Resta, D. Ciancia, A. M. Mogavero, M Lavezzari, R. Taverniti, Morena Di Tommaso, Giovanni Siciliani, Silvia Palmisano   +8 more
openalex   +1 more source

Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies

Ca-A Cancer Journal for Clinicians, 2018
David A Mahvi, Rong Liu, Yolonda L Colson   +2 more
exaly  

Pseudohomozygous type II hyperlipoproteinemia

, 1974
Joel Morganroth, Robert I. Levy, Andrew E. McMahon, Antonio M. Gotto   +3 more
openalex   +1 more source

Cancer of the esophagus and esophagogastric junction—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Deepa T Patil, David P Kelsen
exaly  

Drug Treatment of Type II Hyperlipoproteinemia. Effects on Plasma Lipid and Lipoprotein Levels

, 1980
Donald B. Hunninghake
openalex   +1 more source

Effect of Cholesterol Lowering on Intravascular Pools of TFPI and Its Anticoagulant Potential in Type II Hyperlipoproteinemia

, 1995
John‐Bjarne Hansen, Kirsten Raanaas Huseby, Nils‐Erik Huseby, Per Morten Sandset, Tor-Arne Hanssen, Arne Nordøy   +5 more
openalex   +1 more source